You Do Bio

SKU: NC-0402

Hyacinth Deblocking Reagent with 3% dichloroacetic acid in toluene. A gentle, high-purity solution for 5’-DMT removal in oligonucleotide synthesis workflows.

Download Oligonucleotide Synthesis Reagents Catalogue (PDF)

Price:

Send Request

Hyacinth Deblocking Reagent – 3% Dichloroacetic Acid in Toluene for DNA/RNA Synthesis

Hyacinth Deblocking Reagent is a 3% (v/v) solution of dichloroacetic acid (DCA) in toluene, formulated for gentle and precise deblocking in phosphoramidite-based oligonucleotide synthesis. Used during the detritylation step, this reagent efficiently removes the 5’-DMT protecting group without overexposure or degradation of sensitive sequences.

With a lower acid concentration than standard 10% DCA solutions, Hyacinth is particularly suited for protocols where reaction control, milder conditions, or higher synthesis fidelity is essential — including long oligos or modified bases.

Key Features:

  • 3% dichloroacetic acid (DCA) in toluene

  • Low-strength deblocking for 5’-DMT removal

  • High-purity formulation for DNA and RNA synthesis

  • Compatible with both manual and automated synthesizers

  • Ideal for sensitive or high-precision oligo synthesis

Applications:

  • Deblocking step in oligonucleotide synthesis

  • Detritylation under mild conditions

  • Long or modified oligo workflows

  • DNA/RNA synthesis requiring slower DMT removal

Distribution:

  • Available across Denmark, Sweden, Norway, and Iceland

  • Fast delivery and expert support from YouDoBio

162.24
Select options This product has multiple variants. The options may be chosen on the product page
580.00
Select options This product has multiple variants. The options may be chosen on the product page
Price range: €105.00 through €190.00
Select options This product has multiple variants. The options may be chosen on the product page

Looking for expert lab solutions across Scandinavia?

Scroll to Top
We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.
Accept